Lv5
940 积分 2023-03-16 加入
ASP7266, a Novel Antibody against Human Thymic Stromal Lymphopoietin Receptor for the Treatment of Allergic Diseases
13天前
已完结
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
14天前
已完结
Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial
14天前
已完结
Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study
14天前
已完结
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study
14天前
已完结
Workup of Severe Asthma
16天前
已完结
Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications
1个月前
已完结
Comparison of Omalizumab Treatment Response in Patients with Chronic Spontaneous Urticaria and Symptomatic Dermographism: A Single-Center Retrospective Study
1个月前
已完结
MRGPRX2 gain-of-function mutation drives enhanced mast cell reactivity in chronic spontaneous urticaria
1个月前
已完结
Pan-cancer single-cell landscape of tumor-infiltrating T cells
2个月前
已关闭
皖公网安备34019202002308
